Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations

Triclabendazole is a poorly-water soluble (0.24 μg/mL) compound classified into the Class II/IV of the Biopharmaceutical Classification System. It is the drug of choice to treat fascioliasis, a neglected parasitic disease worldwide disseminated. Triclabendazole is registered as veterinary medicine a...

Descripción completa

Detalles Bibliográficos
Autores principales: Real, Daniel, Hoffmann, Stefan, Leonardi, Darío, Salomon, Claudio, Goycoolea, Francisco M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291145/
https://www.ncbi.nlm.nih.gov/pubmed/30540811
http://dx.doi.org/10.1371/journal.pone.0207625

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291145/
https://www.ncbi.nlm.nih.gov/pubmed/30540811
http://dx.doi.org/10.1371/journal.pone.0207625

Ejemplares similares